Dr. Sarfraz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Alabama at Birmingham
1720 Second Ave S
Birmingham, AL 35294Phone+1 205-975-0255
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2021 - 2024
- Methodist Hospital (Houston)Chief Residency, Internal Medicine, 2020 - 2021
- Methodist Hospital (Houston)Residency, Internal Medicine, 2018 - 2021
- King Edward Medical UniversityClass of 2015
Certifications & Licensure
- AL State Medical License 2024 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Chief Fellow Moffitt/USF, 2023-2024
- Chief Resident Houston Methodist Hospital, 2020-2021
Publications & Presentations
PubMed
- A Cohort Study of the Antitumor Efficacy and Toxicity Profile of Alpelisib for Metastatic or Locally Advanced HR+, HER2- Breast Cancer: A Single-Institution Experience.Humaira Sarfraz, Shahla Bari, Junmin Whiting, Melissa Sur, Qianxing Mo
Oncology. 2024-01-01 - 1 citationsTisagenlecleucel: CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma.Aditi Saha, Khushali Jhaveri, Humaira Sarfraz, Julio C Chavez
Expert Opinion on Biological Therapy. 2023-08-20 - 3 citationsReview of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma.Humaira Sarfraz, Aditi Saha, Khushali Jhaveri, Dae Won Kim
Current Oncology. 2023-05-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: